Robert G. Eisler
Delaware
Grant & Eisenhofer P.A.
123 Justison Street
7th Floor
Wilmington, DE 19801
Tel: (302) 622-7030
Email:
reisler@gelaw.com
Web:
www.gelaw.com
Robert Eisler is a principal at Grant & Eisenhofer and leads the firm’s antitrust practice. Mr. Eisler has been involved in many significant antitrust class action cases over the course of his career. He is experienced in numerous industries, including pharmaceuticals, paper products, construction materials, industrial chemicals, processed foods, securities, and consumer goods.
Mr. Eisler is currently serving as co-lead counsel in several cases, including In re Seroquel Antitrust Litigation, In re London Silver Fixing, Ltd. Antitrust Litigation and In re Keurig Green Mountain Single-Serve Coffee Antitrust Litigation. He has served as lead or co-lead counsel in many other significant antitrust cases, including In re Buspirone Antitrust Litigation (which led to a $90 million settlement in which presiding Judge Koeltl stated that the plaintiffs’ attorneys had done “a stupendous job”), In re Ciprofloxacin Hydrochloride Antitrust Litigation, In re Flat Glass Antitrust Litigation, and In re Municipal Derivatives Antitrust Litigation.
Mr. Eisler has played major roles in a number of other significant antitrust cases, including In re Polyurethane Foam Antitrust Litigation, In re Blue Cross/Blue Shield Antitrust Litigation, In re Containerboard Antitrust Litigation and In re Linerboard Antitrust Litigation.
He also has significant experience litigating antitrust matters in the UK and the Netherlands including cases concerning cartels in a number of industries, such as air cargo services, air passenger services, automotive glass, medium and heavy trucks and pharmaceuticals, among others.
In addition to his antitrust work, Mr. Eisler has extensive experience in securities, derivative, complex commercial and class action litigation at the trial and appellate levels. He has been involved in numerous securities and derivative litigation matters on behalf of public pension funds, municipalities, mutual fund companies and individual investors in state and federal courts.
Mr. Eisler graduated from LaSalle University in 1986, and in 1989, from Villanova University School of Law.
Admissions
-
New York
-
Pennsylvania
G&E’s antitrust practice group concentrates on complex antitrust class and individual actions. The Firm’s antitrust attorneys have been recognized by courts and colleagues across the country and regularly speak at major conferences, as well as contribute materials to academic and other publications. G&E’s antitrust attorneys have collected settlements and judgments on behalf of classes and individuals totaling well over a billion dollars.
The Firm presently serves or has served as lead counsel, on the Plaintiff’s Steering Committee, or on the Executive Committee in several notable antitrust cases, including:
- In re Blue Cross Blue Shield Antitrust Litigation
- In re Payment Card Interchange Fee and Merchant Discount Antitrust Litigation
- In re London Silver Fixing Antitrust Litigation
- In re Keurig Green Mountain Single-Serve Coffee Antitrust Litigation
- In re Humira (Adalimumab) Antitrust Litigation
- In re Generic Pharmaceuticals Pricing Antitrust Litigation
- In re Novartis and Par Antitrust Litigation (Exforge)
- In re NCAA Student-Athlete Name & Likeness Licensing Litigation
- Blessing v. Sirius XM Radio, Inc.
- In re Municipal Derivatives Antitrust Litigation
- In re Lithium-Ion Batteries Antitrust Litigation
- In re Polyurethane Foam Antitrust Litigation
Grant & Eisenhofer is a mission-driven legal powerhouse that has evolved into a global leader in complex, high-stakes plaintiff advocacy.
Since opening its doors over 25 years ago, G&E has been a pacesetter in U.S. and international securities litigation and corporate governance, while significantly expanding to encompass environmental, mass torts, antitrust, bankruptcy, birth injury, civil rights and consumer protection litigation.
With its focus on promoting its clients’ priorities, the Firm founded the G&E ESG Institute, a non-profit organization that harnesses its members’ legal skills to pursue significant ESG goals. Dedicated to these urgent values, G&E has vindicated the rights of states and municipalities suffering lasting damage from toxic environmental harms; consumers injured by faulty manufacturing and other corporate wrongdoing; and patients harmed by pharmaceutical and health care product companies’ defective drugs and medical devices, to name just a few.